Recruitment For Rezolute's Pediatric Congenital Hyperinsulinism Trial

Rezolute, a clinical-stage biopharmaceutical company specializing in the development of innovative drug therapies to improve the lives of patients with metabolic and orphan diseases, was recruiting pediatric patients for a Congenital Hyperinsulinism (HI) trial. Struggling to find applicable ultra-rare disease patients among other challenges, such as making investments with ROI, increasing awareness of the clinical trial globally, and managing internal and external vendors centrally, the biopharm reached out to Citeline.

Explore how Citeline was able to assist by launching a trial education website for Rezolute, deploying pre-screeners for caregivers, and tapping into several different recruitment partners simultaneously, and more by downloading the case study below.